Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Spinal Cord Injury With Early Normobaric Hyperoxia - A Phase IIa Feasibility Trial

NCT07465302 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT07465302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Spinal Cord Injury With Early Normobaric Hyperoxia - A Phase IIa Feasibility Trial
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2026
Completion date
September 30, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic spinal cord injuries